These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7297544)

  • 1. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
    Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
    Chay S; Woods WE; Nugent TE; Weckman T; Houston T; Sprinkle F; Blake JW; Tobin T; Soma LR; Yocum J
    J Vet Pharmacol Ther; 1984 Dec; 7(4):265-76. PubMed ID: 6512917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse.
    Lees P; Taylor JB; Higgins AJ; Sharma SC
    J Vet Pharmacol Ther; 1986 Jun; 9(2):204-12. PubMed ID: 3723663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of phenylbutazone from a paste formulation administered orally to the horse.
    Lees P; Higgins AJ; Mawhinney IC; Reid DS
    Res Vet Sci; 1986 Sep; 41(2):200-6. PubMed ID: 3775111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylbutazone in the horse: a review.
    Tobin T; Chay S; Kamerling S; Woods WE; Weckman TJ; Blake JW; Lees P
    J Vet Pharmacol Ther; 1986 Mar; 9(1):1-25. PubMed ID: 3517382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P; Maitho TE; Taylor JB
    Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
    Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
    Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
    Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
    Landuyt J; Delbeke FT; Debackere M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P; Ayliffe T; Maitho TE; Taylor JB
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
    Keegan KG; Messer NT; Reed SK; Wilson DA; Kramer J
    Am J Vet Res; 2008 Feb; 69(2):167-73. PubMed ID: 18241011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronopharmacokinetics of phenylbutazone in the horse. Application to antidoping control].
    Jaussaud P; Courtot D; Doron P; Guyot JL
    Ann Rech Vet; 1985; 16(4):385-91. PubMed ID: 4091494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness.
    Hu HH; MacAllister CG; Payton ME; Erkert RS
    J Am Vet Med Assoc; 2005 Feb; 226(3):414-7. PubMed ID: 15702692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.